ArticleClinical pharmacokinetics2024

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA Carboxylase.

Elijah J Weber et al.PubMed ↗Publisher ↗

No numbers read from the abstract.